Humanized monoclonal Antibody hPAM4

Details for Australian Patent Application No. 2008212083 (hide)

Owner Immunomedics, Inc

Inventors Hansen, Hans; Qu, Zhengxing; Goldenberg, David M.

Agent Davies Collison Cave

Pub. Number AU-B-2008212083

Parent 2003277087

Filing date 10 September 2008

Wipo publication date 2 October 2008

Acceptance publication date 9 June 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

25 September 2008 Complete Application Filed

2 October 2008 Application Open to Public Inspection

  Published as AU-B-2008212083

9 June 2011 Application Accepted

  Published as AU-B-2008212083

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008212084-Visual obturator

2008212082-Electric power-feeding structure